Assembly Biosciences ASMB Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's other accrued liabilities?
- Assembly Biosciences (ASMB) reported other accrued liabilities of $2.66M in Q1 2026.
- How has Assembly Biosciences's other accrued liabilities changed year-over-year?
- Assembly Biosciences's other accrued liabilities increased by 15.7% year-over-year, from $2.3M to $2.66M.
- What is the long-term trend for Assembly Biosciences's other accrued liabilities?
- Over 5 years (2020 to 2025), Assembly Biosciences's other accrued liabilities has grown at a -8.4% compound annual growth rate (CAGR), from $11.99M to $7.75M.